Frödin JE - Search Results

1

Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families.

Tannergård P, Lipford JR, Kolodner R, Frödin JE, Nordenskjöld M, Lindblom A. Tannergård P, et al. Among authors: frodin je. Cancer Res. 1995 Dec 15;55(24):6092-6. Cancer Res. 1995. PMID: 8521398

2

A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families.

Karimi M, von Salomé J, Aravidis C, Silander G, Askmalm MS, Henriksson I, Gebre-Medhin S, Frödin JE, Björck E, Lagerstedt-Robinson K, Lindblom A, Tham E. Karimi M, et al. Among authors: frodin je. Hered Cancer Clin Pract. 2018 Oct 23;16:16. doi: 10.1186/s13053-018-0098-9. eCollection 2018. Hered Cancer Clin Pract. 2018. PMID: 30386444 Free PMC article.

3

Induction of IgG subclass responses in colorectal carcinoma patients vaccinated with recombinant carcinoembryonic antigen.

Ullenhag GJ, Frödin JE, Strigård K, Mellstedt H, Magnusson CG. Ullenhag GJ, et al. Among authors: frodin je. Cancer Res. 2002 Mar 1;62(5):1364-9. Cancer Res. 2002. PMID: 11888906

4

A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer.

Malmberg KJ, Lenkei R, Petersson M, Ohlum T, Ichihara F, Glimelius B, Frödin JE, Masucci G, Kiessling R. Malmberg KJ, et al. Among authors: frodin je. Clin Cancer Res. 2002 Jun;8(6):1772-8. Clin Cancer Res. 2002. PMID: 12060616

5

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.

Liljefors M, Nilsson B, Hjelm Skog AL, Ragnhammar P, Mellstedt H, Frödin JE. Liljefors M, et al. Among authors: frodin je. Int J Cancer. 2003 Jul 10;105(5):717-23. doi: 10.1002/ijc.11139. Int J Cancer. 2003. PMID: 12740924 Free article.

6

Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.

Ullenhag GJ, Frödin JE, Jeddi-Tehrani M, Lidströmer N, Strigård K, Eriksson E, Samanci A, Choudhury A, Nilsson B, Rossmann ED, Mosolits S, Mellstedt H. Ullenhag GJ, et al. Among authors: frodin je. Clin Cancer Res. 2004 May 15;10(10):3273-81. doi: 10.1158/1078-0432.CCR-03-0706. Clin Cancer Res. 2004. PMID: 15161680 Clinical Trial.

7

Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients.

Mosolits S, Markovic K, Frödin JE, Virving L, Magnusson CG, Steinitz M, Fagerberg J, Mellstedt H. Mosolits S, et al. Among authors: frodin je. Clin Cancer Res. 2004 Aug 15;10(16):5391-402. doi: 10.1158/1078-0432.CCR-04-0425. Clin Cancer Res. 2004. PMID: 15328177

8

T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.

Mosolits S, Markovic K, Fagerberg J, Frödin JE, Rezvany MR, Kiaii S, Mellstedt H, Jeddi-Tehrani M. Mosolits S, et al. Among authors: frodin je. Cancer Immunol Immunother. 2005 Jun;54(6):557-70. doi: 10.1007/s00262-004-0620-y. Epub 2004 Nov 27. Cancer Immunol Immunother. 2005. PMID: 15570423 Free PMC article.

9

Lung cancer.

Frödin JE. Frödin JE. Acta Oncol. 1996;35 Suppl 7:46-53. doi: 10.3109/02841869609101662. Acta Oncol. 1996. PMID: 9154094

10

Prostate cancer.

Frödin JE. Frödin JE. Acta Oncol. 1996;35 Suppl 7:70-4. doi: 10.3109/02841869609101665. Acta Oncol. 1996. PMID: 9154097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page